scispace - formally typeset
M

Marco Lopez-Ilasaca

Researcher at Brigham and Women's Hospital

Publications -  22
Citations -  2195

Marco Lopez-Ilasaca is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Angiotensin II & Angiotensin II receptor type 1. The author has an hindex of 17, co-authored 22 publications receiving 2101 citations.

Papers
More filters
Journal ArticleDOI

Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.

TL;DR: MSC-Akt improved early repair despite transient engraftment, low levels of cellular fusion, and differentiation, and further confirm the recently reported data that early paracrine mechanisms mediated by MSC are responsible for enhancing the survival of existing myocytes and that Akt could alter the secretion of various cytokines and growth factors.
Journal ArticleDOI

Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells.

TL;DR: It is concluded that transplantation of autologous EPCs overexpressing eNOS in injured vessels enhances the vasculoprotective properties of the reconstituted endothelium, leading to inhibition of neointimal hyperplasia.
Journal ArticleDOI

Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10.

TL;DR: The results suggest that adiponectin triggers a multifaceted response in human macrophages by inducing the expression of various anti-inflammatory proteins that act at different levels in concert to suppress macrophage activation.
Journal ArticleDOI

The Angiotensin II Type I Receptor-associated Protein, ATRAP, Is a Transmembrane Protein and a Modulator of Angiotensin II Signaling

TL;DR: ATRAP is characterized as a transmembrane protein localized in intracellular trafficking vesicles and plasma membrane that functions as a modulator of angiotensin II-induced signal transduction and a moderate decrease in the generation of inositol lipids.